Division of Hematology/Oncology University of Alabama at Birmingham

Birmingham, Alabama

0 studies enrolling now · 1 studies all time

What they study most

Breast Neoplasms, Neoplasm Metastasis

Studies at this site

• Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer — Stopped early